Page results
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Information about staff who work in the Macmillan Support and Information Service.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
This page explains what an intra-oral scanner is and what it is used for.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Patient information on managing pain
File results
-
FOI/2023/0461 - UCLH operating system software/ data centres hybrid cloud
-
FOI/2023/0459 - Multiple myeloma treatment
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0458 - Patient trolleys
-
FOI/2023/0457 - Psychiatric/ behavioural problems linked to psychiatric disorders use of force policies
-
FOI/2023/0455 - NHS remediating elective surgery operations
-
FOI/2023/0453 - Patient transport home bookings
-
FOI/2023/0452 - Eating disorders
-
FOI/2023/0246 - Digital services used for patient care
-
FOI/2023/0561 - Birthrate Plus